Copper-Catalyzed Asymmetric Conjugate Addition
2
11.6, JH,H = 9.6 Hz, 1 H, CH), 3.22–3.12 (m, 1 H), 1.75–0.97 (2 (E)- and (Z)-(4-Phenylhex-2-en-2-yloxy)trimethylsilane (9). (E)-9:[12]
m, 10 H) ppm. 13C NMR (125 MHz, CDCl3): δ = 199.0, 153.4,
125.1, 37.3, 32.2, 31.5, 25.8, 25.3 ppm. HRMS (EI): calcd. for
C10H16O 152.12012; found 152.12031.
1H NMR (400 MHz, CDCl3): δ = 7.30–7.24 (m, 2 H, Ar), 7.21–
7.12 (m, 3 H, Ar), 4.83 (d, JH,H = 9.6 Hz, 1 H, CH), 3.22–3.15
1
(m, 1 H, CH), 1.76 (s, 3 H, Me), 1.67–1.54 (m, 2 H, CH2), 0.89 (t,
1JH,H = 7.6 Hz, 3 H, Me), 0.18 (s, 9 H, SiMe3) ppm. 13C NMR
(100 MHz, CDCl3): δ = 148.0, 146.4, 128.2, 127.2, 125.6, 112.7,
General Procedure for Cu-Catalyzed ACA of Et2Zn:[10] A solution
of Cu(OAc)2·H2O (0.02 mmol) and a phosphoramidite-type ligand
(0.04 mmol) in dry diethyl ether (2.5 mL) was stirred at room tem-
perature for 30 min and then cooled to –30 °C. Et2Zn (1.2 equiv.,
1.2 mL of a 1.0 solution in hexane) was added dropwise in such
a way that the temperature did not rise above –30 °C. The solution
was stirred for 5 min, and the Michael acceptor (1.0 mmol) in dry
diethyl ether (0.5 mL) was added dropwise. The reaction mixture
was stirred at –30 °C overnight before the reaction was quenched
with a 2 aqueous solution of HCl.
1
45.5, 30.7, 18.2, 12.2 ppm. (Z)-9: H NMR (400 MHz, CDCl3): δ
1
= 7.30–7.24 (m, 2 H, Ar), 7.21–7.12 (m, 3 H), 4.63 (d, JH,H
=
9.9 Hz, 1 H, CH), 3.54–3.47 (m, 1 H, CH), 1.79 (s, 3 H, Me), 1.79–
1
1.67 (m, 2 H, CH2), 0.85 (t, JH,H = 7.3 Hz, 3 H, Me), 0.14 (s, 9
H, SiMe3) ppm. 13C NMR (100 MHz, CDCl3): δ = 146.6, 146.5,
128.1, 127.5, 125.5, 112.8, 43.4, 30.2, 22.7, 12.3, 0.7 ppm.
(E)- and (Z)-(4-Ethyloct-2-en-2-yloxy)trimethylsilane (10): IR
(neat): ν = 2958, 2922, 2856, 1670, 1251, 842, 632 cm–1. HRMS
˜
(EI): calcd. for C13H28OSi 228.190944; found 228.190840. The en-
antiomeric excess was measured by chiral GC on deprotected
1-Nitro-2-phenylbutane (5):[10] 1H NMR (500 MHz, CDCl3): δ =
7.47–7.26 (m, 5 H, Ar), 4.72–4.64 (m, 2 H, CH2), 3.51–3.45 (m, 1
1
1
ketone. (E)-10: H NMR (500 MHz, CDCl3): δ = 4.36 (d, JH,H
=
1
H, CH), 1.92–1.77 (m, 2 H, CH2), 0.96 (t, JH,H = 7.3 Hz, 3 H,
10.1 Hz, 1 H, CH), 1.94–1.85 (m, 1 H, CH), 1.73 (s, 3 H, Me),
1.44–1.11 (m, 6 H), 0.89–0.83 (t, 3 H, Me), 0.19 (s, 9 H, SiMe3)
ppm. 13C NMR (125 MHz, CDCl3): δ = 147.4, 114.1, 39.7, 36.1,
29.7, 22.9, 18.2, 14.1, 11.9, 0.32 ppm. (Z)-10: 1H NMR (500 MHz,
Me) ppm. 13C NMR (125 MHz, CDCl3): δ = 139.2, 128.8, 127.5,
127.4, 80.7, 45.9, 26.1, 11.4 ppm. The enantiomeric excess was mea-
sured by chiral GC [100–0–1–170; Rt1 = 15.3 min, (S); Rt2
15.8 min, (R); lipodex E].
=
1
CDCl3): δ = 4.15 (d, JH,H = 9.5 Hz, 1 H, CH), 2.33–2.23 (m, 1 H,
4-Phenylhexan-2-one (6):[10] 1H NMR (300 MHz, CDCl3): δ = 7.35–
7.20 (m, 5 H, Ar), 3.12–3.00 (m, 1 H, CH), 2.76 (d, 1JH,H = 7.3 Hz,
2 H, CH2), 2.05 (s, 3 H, Me), 1.79–1.53 (m, 2 H, CH2), 0.82 (t,
1JH,H = 7.3 Hz, 3 H, Me) ppm. 13C NMR (75 MHz, CDCl3): δ =
207.9, 144.2, 50.5, 42.9, 30.5, 29.3, 11.9 ppm. The enantiomeric ex-
cess was measured by chiral GC [lipodex E; isotherm 75 °C; Rt1 =
35.05 min, (S); Rt2 = 37.66 min, (R)].
CH), 1.79 (s, 3 H, Me), 1.44–1.11 (m, 6 H), 0.89–0.83 (t, 3 H, Me),
0.19 (s, 9 H, SiMe3) ppm. 13C NMR (125 MHz, CDCl3): δ = 146.1,
113.9, 36.7, 35.2, 29.7, 28.5, 23.0, 22.7, 14.1, 11.8, 0.8 ppm.
(Z)- and (E)-(4-Cyclohexylhex-2-en-2-yloxy)trimethylsilane (11): IR
(neat): ν = 2956, 2925, 2853, 1738, 1366, 1217 cm–1. HRMS (EI):
˜
calcd. for C15H30OSi 254.206594; found 254.206540. The enantio-
meric excess was measured by chiral GC on deprotected ketone.
(E)-11: 1H NMR (500 MHz, CDCl3): δ = 4.48 (d, 1JH,H = 10.8 Hz,
1 H, CH), 2.22–2.17 (m, 1 H, CH), 1.77 (s, 3 H, Me), 1.74–1.67
(m, 5 H), 1.57–1.43 (m, 1 H), 1.29–1.14 (m, 5 H), 1.10–0.94 (m, 2
4-Ethyloctan-2-one (7):[10] 1H NMR (300 MHz, CDCl3): δ = 2.20
1
(d, JH,H = 6.8 Hz, 2 H, CH2), 1.98 (s, 3 H, Me), 1.77–1.67 (m, 1
H, CH), 1.24–1.03 (m, 8 H), 0.74 (t, 1JH,H = 6.8 Hz, 3 H, Me), 0.71
1
H), 0.88 (t, JH,H = 7.3 Hz, 3 H, Me), 0.25 (s, 9 H, SiMe3) ppm.
1
(t, JH,H = 7.5 Hz, 3 H, Me) ppm. 13C NMR (75 MHz, CDCl3):
13C NMR (125 MHz, CDCl3): δ = 146.4, 111.9, 43.0, 42.2, 31.5,
29.4, 26.9, 26.7, 26.1, 22.8, 12.1, 0.4 ppm. (Z)-11: 1H NMR
δ = 208.7, 48.1, 35.0, 33.0, 28.6, 26.1, 22.7, 13.8, 10.5 ppm. The
enantiomeric excess was measured by chiral GC [lipodex E; 60–15–
20–170; Rt1 = 15.8 min, (+)-(R); Rt2 = 16.1 min, (–)-(S)].
1
(500 MHz, CDCl3): δ = 4.25 (d, JH,H = 9.8 Hz, 1 H, CH), 1.85 (s,
3 H, Me), 1.83–1.80 (m, 1 H, CH), 1.74–1.67 (m, 5 H), 1.57–1.43
1
4-Cyclohexylhexan-2-one (8): H NMR (400 MHz, CDCl3):[10] δ =
1
(m, 1 H), 1.29–1.14 (m, 5 H), 1.10–0.94 (m, 2 H), 0.88 (t, JH,H
=
7.3 Hz, 3 H, Me), 0.24 (s, 9 H, SiMe3) ppm. 13C NMR (125 MHz,
CDCl3): δ = 147.7, 111.7, 45.4, 42.2, 31.2, 29.6, 26.9, 26.8, 26.7,
25.2, 18.3, 12.1, 0.9 ppm.
2.40–2.18 (AB system, 2 H, CH2), 2.09 (s, 3 H, Me), 1.74–0.85 (2
1
m, 14 H, c-Hex, CH2), 0.80 (t, JH,H = 3.0 Hz, 3 H, Me) ppm. 13C
NMR (100 MHz, CDCl3): δ = 209.5, 45.6, 40.6, 40.0, 30.1, 30.1,
29.1, 29.1, 26.6, 23.9, 11.7 ppm. The enantiomeric excess was mea-
sured by chiral GC [lipodex E; isotherm 70 °C; Rt1 = 34.3 min, (S);
Rt2 = 36.3 min, (R)].
Acknowledgments
General Procedure for the Tandem Cu-Catalyzed ACA of Et2Zn/
Silylation Sequence:[12] A solution of Cu(OAc)2·H2O (0.02 mmol)
and a phosphoramidite-type ligand (0.04 mmol) in dry diethyl ether
(2.5 mL) was stirred at room temperature for 30 min and then co-
oled to –30 °C. Et2Zn (1.2 equiv., 1.2 mL of a 1.0 solution in
hexane) was added dropwise so that the temperature did not rise
above –30 °C. The solution was stirred for 5 min, and the Michael
acceptor (1.0 mmol) in dry diethyl ether (0.5 mL) was added drop-
wise. The reaction mixture containing the zinc enolate species was
stirred at –30 °C overnight. A solution of Et2Zn (0.1 mL) was
added to TMSOTf (0.218 mL, 1.2 mmol) in order to eliminate
traces of water. The mixture was added to the solution containing
the zinc enolate at –30 °C and stirred overnight. The reaction mix-
ture was diluted with dry diethyl ether (2 mL) and filtered through
SiO2 (2 g) previously neutralized with Et3N (0.25 mL in 7 mL
Et2O). The solvents were removed in vacuo. The crude mixture
was purified by fast flash chromatography on SiO2 (8 g) previously
neutralized with Et3N (0.25 mL) and with pentane as eluent to give
pure silylenol ether as a mixture of (E) and (Z) compounds.
The authors thank the Swiss National Research Foundation (No.
20-068095.02 and COST action D24/0003/01 (OFES contract No.
c02.0027) for financial support.
[1] For reviews, see: a) N. Krause in Modern Organocopper Chem-
istry, Wiley-VCH, Weinheim, 2001; b) M. P. Sibi, S. Manyem,
Tetrahedron 2000, 56, 8033–8061; c) N. Krause, A. Hoffmann-
Röder, Synthesis 2001, 7, 171–196; d) A. Alexakis, C. Benhaim,
Eur. J. Org. Chem. 2002, 3221–3236; e) T. Hayashi, Acc. Chem.
Res. 2000, 33, 354 –362.
[2] T. Imamoto, T. Mukaiyama, Chem. Lett. 1980, 45–46.
[3] A. W. Hird, A. H. Hoveyda, Angew. Chem. Int. Ed. 2003, 42,
1276–1279.
[4] S.-Y. Wang, S.-J. Ji, T.-P. Loh, J. Am. Chem. Soc. 2007, 129,
276–277.
[5] S. R. Harutyunyan, F. Lopez, W. R. Browne, A. Correa, D.
Pena, R. Badorrey, A. Meetsma, A. J. Minnaard, B. L. Feringa,
J. Am. Chem. Soc. 2006, 128, 9103–9118.
[6] T. Ohwada, T. Ohta, K. Shudo, J. Am. Chem. Soc. 1986, 108,
3029–3032.
Eur. J. Org. Chem. 2007, 5852–5860
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5859